Regenerex Pharma (RGPX) Revenue (2014 - 2020)
Regenerex Pharma (RGPX) reported Revenue of $181.0 for Q4 2020, down 89.17% year-over-year from $1671.0 in Q1 2020, and up 50.83% quarter-over-quarter from $120.0 in Q3 2020.
Regenerex Pharma (RGPX) Revenue (2014 - 2020) Analysis & Trends
Regenerex Pharma (RGPX) has 3 years of Revenue data on file, last reported at $181.0 in Q4 2020.
- Revenue for Q4 2020 came in at $181.0, down 89.17% year-over-year; the trailing twelve-month figure through Dec 2020 was $1315.0 (changed N/A YoY), and the FY2020 annual result was $2608.0, changed N/A from the prior year.
- Revenue improved to $181.0 in Q4 2020 per RGPX's latest filing, from $120.0 in the prior quarter.
- Over five years, Revenue peaked at $1671.0 in Q4 2019 and troughed at $77.0 in Q2 2020.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 181.00 |
| Sep 30, 2020 | 120.00 |
| Jun 30, 2020 | 77.00 |
| Mar 31, 2020 | 937.00 |
| Dec 31, 2019 | 1,671.00 |
| Aug 31, 2014 | 9,239.00 |